Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abstaining, African, AG, alleviate, authoritative, Boston, Cadillac, categorized, classification, CMMI, component, Concurrently, curative, cut, debate, deficiency, device, discretionary, Distinguishing, divisional, doubt, earned, eighteen, exam, extraordinary, feature, footprint, geographic, hinder, HK, impending, implanted, infused, inhaled, injected, Innovation, innovative, inseverable, instilled, Joseph, Jr, judicial, KPMG, Latin, loan, mailing, medicine, nominal, Northern, Notwithstanding, Pacific, PDPRA, PDUFA, penalize, placement, political, proliferative, prolonged, properly, Proportionate, radiation, reauthorization, recoverability, redemption, remeasured, remeasurement, Rescue, retroactively, retrospectively, revalued, RU, satisfaction, senior, split, standing, stay, sue, surgery, Treasury, twenty, User, wound
Removed:
abort, appeal, apportioned, BBA, biologic, biosimilar, Bipartisan, broadening, call, ceiling, cited, Constellation, constitutional, constitutionality, copy, depression, discount, dispensed, exempting, expanding, facilitated, favored, federally, forced, gap, incoming, issuing, judge, landscape, lowering, main, modify, molibresib, movement, nation, nondeductible, ordinarily, pathway, permitting, poverty, promoting, recession, redirect, released, Room, rural, Senate, simplify, Simplifying, undermining, underwriting, underwritten, upheld, Washington
Filing tables
Filing exhibits
Related press release
CKPT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-251005, 333-270474, 333-270843) on Form S-3 and (Nos. 333-216856, 333-221488, 333-251000, 333-268740) on Form S-8 of our report dated March 31, 2023, with respect to the financial statements of Checkpoint Therapeutics, Inc.
| | | | |
Boston, Massachusetts
March 31, 2023